MindWalk Holdings (HYFT) EPS (Weighted Average and Diluted) (2022 - 2025)
MindWalk Holdings (HYFT) reported EPS (Weighted Average and Diluted) of $448.96 for Q1 2025, up 104.61% year-over-year from $219.43 in Q1 2024, and up 104.61% quarter-over-quarter from -$9747.1 in Q1 2024.
MindWalk Holdings (HYFT) EPS (Weighted Average and Diluted) (2022 - 2025) Analysis & Trends
MindWalk Holdings (HYFT) has 4 years of EPS (Weighted Average and Diluted) data on file, last reported at $448.96 in Q1 2025.
- EPS (Weighted Average and Diluted) for Q1 2025 came in at $448.96, up 104.61% year-over-year; the trailing twelve-month figure through Jan 2025 was $448.96 (up 104.61% YoY), and the FY2025 annual result was -$0.65, up 13.16% from the prior year.
- EPS (Weighted Average and Diluted) advanced to $448.96 in Q1 2025 per HYFT's latest filing, from -$9747.1 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $448.96 in Q1 2025 and troughed at -$12092.0 in Q4 2023.
- A 4-year average of -$5343.1 and a median of -$5325.6 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) tumbled 103548468.51% in 2023, then jumped 104.61% in 2025.
- A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.01 in 2022, then plunged by 103548468.51% to -$12092.0 in 2023, then rose by 19.39% to -$9747.1 in 2024, then soared by 104.61% to $448.96 in 2025.
- Business Quant data shows HYFT's EPS (Weighted Average and Diluted) at $448.96 in Q1 2025, -$9747.1 in Q1 2024, and -$12092.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.61 |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2025 | 448.96 |
| Jan 31, 2024 | -9,747.06 |
| Oct 31, 2023 | -12,092.00 |
| Jan 31, 2023 | -5,325.58 |
| Oct 31, 2022 | -0.01 |